Cargando…
Eradication efficacy of high-dose amoxicillin and proton pump inhibitor compared with quadruple therapy contained bismuth in the treatment of Helicobacter pylori
BACKGROUND: Helicobacter pylorus is one of the most common bacterial infections affecting the world’s population. Peptic ulcer disease is caused by H. pylori and the use of nonsteroidal anti-inflammatory drugs. The aim of this study was to assessment of two antibiotic regimens in the treatment of H....
Autores principales: | Hajiani, Eskandar, Hashemi, Seid Jalal, Parsi, Abazar, Seyedian, Seid Saeed, Ramim, Tayeb, Sabbaghan, Amin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041035/ https://www.ncbi.nlm.nih.gov/pubmed/36994069 http://dx.doi.org/10.4103/jfmpc.jfmpc_1035_22 |
Ejemplares similares
-
Sequential Therapy vs Quadruple Therapy for Helicobacter pylori Eradication in South West of Iran
por: Masjedizadeh, Abdol Rahim, et al.
Publicado: (2014) -
Comparison of the Dual Therapy of Ilaprazole-Amoxicillin and the Bismuth Quadruple Therapy of Ilaprazole-Amoxicillin-Furazolidone-Bismuth Glycyrrhizinate for Eradication of Helicobacter pylori
por: Niu, Min, et al.
Publicado: (2022) -
Levofloxacin+Tetracycline Quadruple Regimen for Eradication of Helicobacter pylori: A Multicenter Multinational Randomized Controlled Trial
por: Alavinejad, Pezhman, et al.
Publicado: (2023) -
Association between high-sensitivity-CRP and liver elastography and cardiac ischemic diseases in patients with fatty liver
por: Nayebi, Morteza, et al.
Publicado: (2022) -
Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori
por: Gisbert, Javier P, et al.
Publicado: (2012)